Colorectal Disease

Colorectal Disease is the official journal of the Association of Coloproctology of Great Britain and Ireland, the European Society of Coloproctology and the Greek Society of Coloproctology, and Wiley publishes it.结直肠疾病是英国与爱尔兰结直肠外科协会，欧洲结直肠外科学会与希腊结直肠外科学会的机关刊，由威立出版。

Its 2025 impact factor is 2.3 and the five-year figure is 2.9.2025 年影响因子 2.3，五年影响因子 2.9。

Twelve issues appear each year, with volume 27 covering 2025 and volume 28 covering 2026.每年出版 12 期，第 27 卷对应 2025 年，第 28 卷对应 2026 年。

Submission is free format through the publisher's ReX system at authors.wiley.com/journal/CODI.投稿走出版方的 ReX 系统，入口是 authors.wiley.com/journal/CODI，不设固定格式。

Original articles stop at 3,000 words with a structured abstract of 250 words.原创论文上限 3000 词，另附 250 词结构式摘要。

Scope

• Original articles on colorectal practice are the first type the journal takes.结直肠临床实践的原创论文是刊物接收的第一类稿件。

• The remit is adult medicine, covering patients older than eighteen with disease of the small bowel, colon, rectum or anus.刊物定位在成人，面向 18 岁以上而病变位于小肠，结肠，直肠或肛门的患者。

• Surgical, medical, nursing, pathology, radiology and oncology teams all fall inside the readership.外科，内科，护理，病理，放射与肿瘤团队都在读者范围内。

• Papers may address epidemiology and aetiology, diagnosis and classification, management, prognosis or long-term sequelae.论文可以讨论流行病学与病因，诊断与分类，处理，预后或长期后遗症。

• Health service organisation, health economics, the conduct of research and the training of clinicians are treated as legitimate subjects.卫生服务组织，卫生经济学，研究方法的规范以及临床人员的培训都算正当选题。

• Sociocultural and political questions, and wider workforce matters, are declared outside the scope.社会文化与政治议题以及更广的人力配置问题，被明确划在范围之外。

• The stated aim is research a practising clinician can use in everyday care.刊物自述的目标是让执业医生在日常诊疗中用得上。

• Systematic reviews count with or without meta-analysis.系统综述无论是否附荟萃分析都收。

• Technical notes describe an operative or procedural technique.技术札记介绍手术或操作技巧。

• Opinion pieces carry an argued view rather than new data.观点文章给出有论证的看法，而不是新数据。

• Letters and correspondence answer material the journal has published.读者来信与通信针对刊物已发表的内容。

• Guidelines, consensus statements and Delphi exercises are accepted as their own category.指南，共识声明与德尔菲调查单列一类接收。

• Core outcome sets form another category.核心结局指标集构成另一类。

• Patient-reported outcome measures sit beside them.患者报告结局量表与它们并列。

• Animal studies are excluded by policy.动物研究按政策排除。

• Laboratory work on commercial cell lines is excluded as well.用商业细胞系做的实验室工作同样排除。

• Analyses built on registry data of the SEER kind are turned away.基于 SEER 一类登记库数据的分析不在接收之列。

• Original articles allow four illustrations.原创论文允许 4 幅插图。

• The abstract runs under aim, method, results and conclusion.摘要按目的，方法，结果与结论四段撰写。

• A fifty-word statement answering what the paper adds is compulsory.必须另写一段 50 词的说明，回答这篇论文增加了什么。

• References follow Vancouver style.参考文献采用温哥华格式。

• The relevant EQUATOR checklist has to come with the submission, and randomised trials need CONSORT.投稿须附对应的 EQUATOR 清单，随机对照试验另须 CONSORT。

• Every author needs an ORCID identifier.每位作者都要有 ORCID 标识。

• An authorship declaration form accompanies the manuscript.投稿时还要交一份作者身份声明表。

• Two or more reviewers read each paper, and a statistician reads it as well.每篇论文至少两位评审人，另有一位统计学家过目。

• The median time from submission to a post-review decision is 30 days.从投稿到给出外审后决定的中位时间是 30 天。

• About 30 percent of submissions are turned away at desk within a week.约 30% 的来稿在一周内未经外审即被退回。

• Acceptance sits near 19 percent, and the first decision arrives in three days on average.录用率约 19%，首次决定平均 3 天到手。

• Scopus puts CiteScore at 4.5.斯高帕斯给出的引用分值为 4.5。

• Multimedia material has its own associate editor, which is unusual for a surgical journal of this size.多媒体内容由一位专门的副编辑负责，这在同等规模的外科刊物里并不多见。

History

• Volume 1 number 1 appeared in January 1999 under Blackwell Science in Oxford.第 1 卷第 1 期于 1999 年 1 月在牛津由布莱克韦尔科学社出版。

• MEDLINE and PubMed have covered the journal from volume 5 number 1 in January 2003.MEDLINE 与 PubMed 自 2003 年 1 月第 5 卷第 1 期起收录。

• Embase, Current Contents Clinical Medicine, HEED and the EBSCO academic databases index it alongside MEDLINE.Embase，Current Contents 临床医学版，HEED 与 EBSCO 的学术数据库都和 MEDLINE 一起收录它。

• The library record still gives the frequency as bimonthly, which is out of date.图书馆记录仍把出版频率写成双月刊，这一条已经过时。

• Crossref shows twelve issues in 2025, and the volume count agrees with a monthly schedule.Crossref 显示 2025 年出了 12 期，卷号也对得上月刊节奏。

• The Coden is CODIFU and the print and electronic numbers are 1462-8910 and 1463-1318.刊物代码为 CODIFU，印刷版与电子版号分别是 1462-8910 与 1463-1318。

• The 2021 impact factor was 3.788.2021 年影响因子为 3.788。

• 2022 reached 3.917, the top of the five-year window.2022 年达到 3.917，是这五年窗口的最高点。

• 2023 fell to 2.9 and 2024 to 2.7.2023 年降到 2.9，2024 年为 2.7。

• 2025 came in at 2.3, the lowest of the five.2025 年为 2.3，是五年中的最低值。

• The 2025 window holds 149 articles and 8,273 citations behind them.2025 年窗口内有 149 篇文章，背后是 8273 次被引。

• Gold open access accounted for 45.34 percent of that window.金色开放获取在这一窗口占 45.34%。

• The article influence score of 0.816 ranks 63rd of 300 and sits in the first quartile.论文影响分值 0.816，在 300 种刊中排第 63，属第一四分位。

• The citation indicator of 0.76 places it 131st of 321 in surgery.期刊引文指标 0.76，在外科的 321 种刊中排第 131。

• Clarivate also files it under gastroenterology and hepatology, where it ranks 93rd of 153.科睿唯安另把它归入胃肠病学与肝病学，在该类 153 种刊中排第 93。

• The publisher imprint passed from Blackwell to Wiley, and the Crossref publisher string still reads Wiley with Blackwell in brackets.出版印记由布莱克韦尔转到威立，Crossref 的出版者字段至今仍写作威立并附布莱克韦尔。

• The journal reports 618,889 full-text views and 333 articles published in 2025.刊物公布 2025 年的全文浏览量为 618889 次，当年发表 333 篇。

• Submission to acceptance takes 70 days at the median, and acceptance to publication 27 days.投稿到录用的中位时间 70 天，录用到出版 27 天。

• Authors come mostly from Britain at 19 percent, followed by the United States at 9, Spain and China at 8 each, and Japan at 7.作者来源以英国居首，占 19%，其后是美国 9%，西班牙与中国各 8%，日本 7%。

• Readers are spread more widely, with the United States at 17 percent, China at 15, Britain at 12, and Australia and Japan at 4 each.读者分布更散，美国 17%，中国 15%，英国 12%，澳大利亚与日本各 4%。

Editors

• Steven Brown in Sheffield is editor-in-chief.谢菲尔德的 Steven Brown 担任主编。

• Sue Clark in London is one of three editors.伦敦的 Sue Clark 是三位编辑之一。

• Debby Keller in New York holds the second editorship.纽约的 Debby Keller 是第二位编辑。

• Stavros Antoniou in Thessaloniki holds the third.塞萨洛尼基的 Stavros Antoniou 是第三位。

• Eva Angenete in Gothenburg is an associate editor.哥德堡的 Eva Angenete 是副编辑。

• Stephanie Breukink in Maastricht holds the same rank.马斯特里赫特的 Stephanie Breukink 同为副编辑。

• Gaetano Gallo in Rome is an associate editor.罗马的 Gaetano Gallo 是副编辑。

• Cherry Koh in Sydney holds the same rank.悉尼的 Cherry Koh 同为副编辑。

• Matthew Lee in Birmingham and Dale Vimalachandran in Chester are associate editors.伯明翰的 Matthew Lee 与切斯特的 Dale Vimalachandran 都是副编辑。

• Samson Tou in Derby holds the same rank, as does Omar Faiz in London.德比的 Samson Tou 与伦敦的 Omar Faiz 也任副编辑。

• Gabrielle van Ramshorst in Ghent is an associate editor.根特的 Gabrielle van Ramshorst 是副编辑。

• Tim Eglinton in Christchurch and Adele Sayers in Sheffield complete the associate editors.基督城的 Tim Eglinton 与谢菲尔德的 Adele Sayers 补齐副编辑名单。

• Valerio Celentano in London handles multimedia for the journal.伦敦的 Valerio Celentano 负责刊物的多媒体内容。

• Gareth Ambler in London and Constantinos Koshiaris in Nicosia serve as statistical advisors.伦敦的 Gareth Ambler 与尼科西亚的 Constantinos Koshiaris 担任统计顾问。

• N J Mortensen and R J Nicholls are editors emeriti, and Neil Smart is listed in memoriam.N J Mortensen 与 R J Nicholls 是荣休编辑，Neil Smart 以纪念名单的形式列出。

• The advisory board runs from Buenos Aires and Cape Town through Guangzhou and Mumbai to Toronto and Auckland.顾问委员会从布宜诺斯艾利斯与开普敦一路排到广州与孟买，再到多伦多与奥克兰。

• An early career advisory board sits alongside the main one.在主顾问委员会之外，另设青年顾问委员会。